Nutrition and cancer prevention: A multidisciplinary perspective on human trials

Annual Review of Nutrition

Volumn 24, Issue , 2004, Pages 223-254

  Forman, M R ^a   Hursting, S D ^a   Umar, A ^a   Barrett, J C ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Carcinogenesis; Carotenoids; Diet; Epidemiology; Molecular targets; Retinoids

Indexed keywords

BETA CAROTENE; CALCIUM; RETINOID;

CANCER; CANCER INCIDENCE; CANCER PREVENTION; CANCER RECURRENCE; CANCER RESEARCH; CARCINOGENESIS; COLON POLYP; DIET; DIET SUPPLEMENTATION; DIET THERAPY; DIGESTIVE SYSTEM CANCER; FRUIT; HUMAN; INTESTINE POLYP; LUNG CANCER; NONHUMAN; NUTRITION; PLANT FIBER; PRIORITY JOURNAL; REVIEW; UPPER GASTROINTESTINAL TRACT; VEGETABLE;

DIET; HUMANS; META-ANALYSIS; NEOPLASMS; NUTRITION PHYSIOLOGY; RANDOMIZED CONTROLLED TRIALS;

ANIMALIA;

EID: 3142679267     PISSN: 01999885     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.nutr.24.012003.132315     Document Type: Review

References (108)

1. 1964 Smoking and Health: Report of the Advisory Committee to the Surgeon General of the Public Health Service. 1964. U.S. Publ. Health Serv., Office Surg. Gen. Washington, DC: US GPO
2. Deleted in proof
3. Alam BS, Alam SQ. 1987. The effect of different levels of dietary beta-carotene on DMBA-induced salivary gland tumors. Nutr. Cancer 9:93-101
4. Albanes D, Heinonen OP, Taylor PR, Virtamo J, Edwards BK, et al. 1996. Alpha-tocopherol and beta-carotene supplements and lung cancer incidence in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study: effects of base-line characteristics and study compliance. J. Natl. Cancer Inst. 88:1560-70
5. Albanes D, Virtamo J, Taylor PR, Rautalahti M, Pietinen P, Heinonen OP. 1997. Effects of supplemental beta-carotene, cigarette smoking, and alcohol consumption on serum carotenoids in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study. Am. J. Clin. Nutr. 66:366-72
6. Alberts DS, Martinez ME, Roe DJ, Guillen-Rodriguez JM, Marshall JR, et al. 2000. Lack of effect of a high-fiber cereal supplement on the recurrence of colorectal adenomas. Phoenix Colon Cancer Prevention Physicians' Network. N. Engl. J. Med. 342:1156-62
7. Alpha-Tocopherol β-Carotene Trial. 1994. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group. N. Engl. J. Med. 330:1029-35
8. American Cancer Society. 2003. Cancer Facts and Figures. Atlanta, GA: Amer. Cancer Soc.
9. Baron JA, Beach M, Mandel JS, van Stolk RU, Haile RW, et al. 1999. Calcium supplements for the prevention of colorectal adenomas. Calcium Polyp Prevention Study Group. N. Engl. J. Med. 340:101-7
10. Benner SE, Pajak TF, Lippman SM, Earley C, Hong WK. 1994. Prevention of second primary tumors with isotretinoin in patients with squamous cell carcinoma of the head and neck: long-term follow-up. J. Natl. Cancer Inst. 86:140-41
11. Bingham SA, Day NE, Luben R, Ferrari P, Slimani N, et al. 2003. Dietary fibre in food and protection against colorectal cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC): an observational study. Lancet 361:1496-501
12. Bonithon-Kopp C, Kronborg O, Giacosa A, Rath U, Faivre J. 2000. Calcium and fibre supplementation in prevention of colorectal adenoma recurrence: a randomised intervention trial. European Cancer Prevention Organisation Study Group. Lancet 356:1300-6
13. Bowen PE, Garg V, Stacewicz-Sapuntzakis M, Yelton L, Schreiner RS. 1993. Variability of serum carotenoids in response to controlled diets containing six servings of fruits and vegetables per day. Ann. NY Acad. Sci. 691:241-43
14. Brown ED, Micozzi MS, Craft NE, Bieri JG, Beecher G, et al. 1989. Plasma carotenoids in normal men after a single ingestion of vegetables or purified beta-carotene. Am. J. Clin. Nutr. 49:1258-65
15. Chemoprevention Working Group. 1999. Prevention of cancer in the next millennium: Report of the Chemoprevention Working Group to the American Association for Cancer Research. Cancer Res. 59:4743-58
16. Cortessis V, Thomas DC. 2002. Toxicokinetic genetics: an approach to gene-environment and gene-gene interactions in complex metabolic pathways. In Mechanistic Considerations in the Molecular Epidemiology of Cancer, ed. P Bird, P Boffetta, P Buffler, J Rice. Lyon, France: IARC Scientific
17. Craig WJ. 1997. Phytochemicals: guardians of our health. J. Am. Diet. Assoc. 79(Suppl.2):S199-204
18. DeCosse JJ, Miller HH, Lesser ML. 1989. Effect of wheat fiber and vitamins C and E on rectal polyps in patients with familial adenomatous polyposis. J. Natl. Cancer Inst. 81:1290-97
19. Dimery IW, Hong WK, Lee JJ, Guillory-Perez C, Pham F, et al. 1997. 1 Phase I trial of alpha-tocopherol effects on 13-cis-retinoic acid toxicity. Ann. Oncol. 8:85-89
20. Dimitrov NV, Meyer C, Ullrey DE, Chenoweth W, Michelakis A, et al. 1988. Bioavailability of beta-carotene in humans. Am. J. Clin. Nutr. 48:298-304
21. Earnest DL, Sampliner RE, Roe DJ, van Leeuwen B, Guillen J, et al. 1999. Progress report: the Arizona phase III study of the effect of wheat bran fiber on recurrence of adenomatous colon polyps. Am. J. Med. 106:43-458
22. Faivre J, Couillault C, Kronborg O, Rath U, Giacosa A, et al. 1997. Chemoprevention of metachronous adenomas of the large bowel: design and interim results of a randomized trial of calcium and fibre. ECP Colon Group. Eur. J. Cancer Prev. 6:132-38
23. Fearon ER, Vogelstein B. 1990. A genetic model for colorectal tumorigenesis. Cell 61:759-67
24. Foulds L. 1969. Neoplastic Development. New York: Academic
25. Fuchs CS, Giovannucci EL, Colditz GA, Hunter DJ, Stampfer MJ, et al. 1999. Dietary fiber and the risk of colorectal cancer and adenoma in women. N. Engl. J. Med. 340:169-76
26. Goodman DS, Blomstrand R, Werner B, Huang HS, Shiratori T. 1966. The intestinal absorption and metabolism of vitamin A and beta-carotene in man. J. Clin. Invest. 45:1615-23
27. Hennekens CH, Buring JE, Manson JE, Stampfer M, Rosner B, et al. 1996. Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease. N. Engl. J. Med. 334:1145-49
28. Hofstad B, Almendingen K, Vatn M, Andersen SN, Owen RW, et al. 1998. Growth and recurrence of colorectal polyps: a double-blind 3-year intervention with calcium and antioxidants. Digestion 59:148-56
29. Hofstad B, Vatn MH, Andersen SN, Owen RW, Larsen S, Osnes M. 1998. The relationship between faecal bile acid profile with or without supplementation with calcium and antioxidants on recurrence and growth of colorectal polyps. Eur. J. Cancer Prev. 7:287-94
30. Holt PR. 1999. Dairy foods and prevention of colon cancer: human studies. J. Am. Coll. Nutr. 18:379-91S
31. Hong WK. 1999. Chemoprevention of lung cancer. Oncology (Huntingt.) 13: 135-41
32. Hong WK, Endicott J, Itri LM, Doos W, Batsakis JG, et al. 1986. 13-cis-retinoic acid in the treatment of oral leukoplakia. N. Engl. J. Med. 315:1501-5
33. Hong WK, Lippman SM, Itri LM, Karp DD, Lee JS, et al. 1990. Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck. N. Engl. J. Med. 323:795-801
34. Hong WK, Sporn MB. 1997. Recent advances in chemoprevention of cancer. Science 278:1073-77
35. 14C-labeled vitamin A alcohol and β-carotene in the rat. J. Biol. Chem. 240:2839-45
36. Hursting SD, Slaga TJ, Fischer SM, Di-Giovanni J, Phang JM. 1999. Mechanism-based cancer prevention approaches: targets, examples, and the use of transgenic mice. J. Natl. Cancer Inst. 91:215-25
37. Hursting SD, Switzer BR, French JE, Kari FW. 1993. The growth hormone: insulin-like growth factor 1 axis is a mediator of diet restriction-induced inhibition of mononuclear cell leukemia in Fischer rats. Cancer Res. 53:2750-57
38. Khuri FR, Kim ES, Lee JJ, Winn RJ, Benner SE, et al. 2001. The impact of smoking status, disease stage, and index tumor site on second primary tumor incidence and tumor recurrence in the head and neck retinoid chemoprevention trial. Cancer Epidemiol. Biomarkers Prev. 10:823-29
39. Kim ES, Hong WK, Khuri FR. 2002. Chemoprevention of aerodigestive tract cancers. Annu. Rev. Med. 53:223-43
40. Koo LC. 1997. Diet and lung cancer 20+ years later: more questions than answers? Int. J. Cancer 10(Suppl.):22-29
41. Kuller LH, Shaten BJ, Neaton JD. 1991. Association between baseline risk factors, cigarette smoking, and CHD mortality after 10.5 years. MRFIT Research Group. Prev. Med. 20:655-69
42. Lanza E, Schatzkin A, Daston C, Corle D, Freedman L, et al. 2001. Implementation of a 4-y, high-fiber, high-fruit-and-vegetable, low-fat dietary intervention: results of dietary changes in the Polyp Prevention Trial. Am. J. Clin. Nutr. 74:387-401
43. Lee IM, Cook NR, Manson JE, Buring JE, Hennekens CH. 1999. Beta-carotene supplementation and incidence of cancer and cardiovascular disease: the Women's Health Study. J. Natl. Cancer Inst. 91:2102-6
44. Lee JJ, Hong WK, Hittelman WN, Mao L, Lotan R, et al. 2000. Predicting cancer development in oral leukoplakia: ten years of translational research. Clin. Cancer Res. 6:1702-10
45. Leo MA, Aleynik SI, Alevnik MK, Lieber CS. 1997. Beta-carotene beadlets potentiate hepatotoxicity of alcohol. Am. J. Clin. Nutr. 66:1461-69
46. Deleted in proof
47. Lipkin M. 1974. Phase 1 and phase 2 proliferative lesions of colonic epithelial cells in diseases leading to colonic cancer. Cancer 34(Suppl.):878-88
48. Lipkin M. 2002. Early development of cancer chemoprevention clinical trials: studies of dietary calcium as a chemopreventive agent for human subjects. Eur. J. Cancer Prev. 11 (Suppl. 2):S65-70
49. Lippman SM, Batsakis JG, Toth BB, Weber RS, Lee JJ, et al. 1993. Comparison of low-dose isotretinoin with beta carotene to prevent oral carcinogenesis. N. Engl. J. Med. 328:15-20
50. Lippman SM, Benner SE, Fritsche HA, Lee JS, Hong WK. 1998. The effect of 13-cis-retinoic acid chemoprevention on human serum retinol levels. Cancer Detect. Prev. 22:51-56
51. Lippman SM, Shin DM, Lee JJ, Batsakis JG, Lotan R, et al. 1995. p53 and retinoid chemoprevention of oral carcinogenesis. Cancer Res. 55:16-19
52. Liu C, Lian F, Smith DE, Russell RM, Wang XD. 2003. Lycopene supplementation inhibits lung squamous metaplasia and induces apoptosis via up-regulating insulin-like growth factor-binding protein 3 in cigarette smoke-exposed ferrets. Cancer Res. 63:3138-44
53. Locke FB, King H. 1980. Cancer mortality risk among Japanese in the United States. J. Natl. Cancer Inst. 65:1149-56
54. MacLennan R, Macrae F, Bain C, Battistutta D, Chapuis P, et al. 1995. Randomized trial of intake of fat, fiber, and beta carotene to prevent colorectal adenomas. The Australian Polyp Prevention Project. J. Natl. Cancer Inst. 87:1760-66
55. Mai V, Colbert LH, Berrigan D, Perkins SN, Pfeiffer R, et al. 2003. Calorie restriction and diet composition modulate spontaneous intestinal tumorigenesis in Apc(Min) mice through different mechanisms. Cancer Res. 63:1752-55
56. Mangels AR, Holden JM, Beecher GR, Forman MR, Lanza E. 1993. Carotenoid content of fruits and vegetables: an evaluation of analytic data. J. Am. Diet. Assoc. 93:284-96
57. Mao L, El-Naggar AK, Papadimitrakopoulou V, Shin DM, Shin HC, et al. 1998. Phenotype and genotype of advanced premalignant head and neck lesions after chemopreventive therapy. J. Natl. Cancer Inst. 90:1545-51
58. Martin KR, Barrett JC. 2002. Reactive oxygen species as double-edged swords in cellular processes: low-dose cell signaling versus high-dose toxicity. Hum. Exp. Toxicol. 21:71-75
59. Martin KR, Trempus C, Saulnier M, Kari FW, Barrett JC, French JE. 2001. Dietary N-acetyl-L-cysteine modulates benzo[a]pyrene-induced skin tumors in cancer-prone p53 haploinsufficient Tg.AC (v-Ha-ras) mice. Carcinogenesis 22: 1373-78
60. Martinez ME, Reid ME, Guillen-Rodriguez J, Marshall JR, Sampliner R, et al. 1998. Design and baseline characteristics of study participants in the Wheat Bran Fiber Trial. Cancer Epidemiol. Biomarkers Prev. 7:813-16
61. Mathews-Roth MM. 1986. Beta-carotene therapy for erythropoietic protoporphyria and other photosensitivity diseases. Biochimie 68:875-84
62. Mathews-Roth MM. 1990. Plasma concentrations of carotenoids after large doses of beta-carotene. Am. J. Clin. Nutr. 52:500-1
63. McKeown-Eyssen GE, Bright-See E, Bruce WR, Jazmaji V, Cohen LB, et al. 1994. A randomized trial of a low fat high fibre diet in the recurrence of colorectal polyps. Toronto Polyp Prevention Group. J. Clin. Epidemiol. 47:525-36
64. McTiernan A, Kooperberg C, White E, Wilcox S, Coates R, et al. 2003. Recreational physical activity and the risk of breast cancer in postmenopausal women: the Women's Health Initiative Cohort Study. JAMA 290:1331-36
65. Mertz W. 1981. The essential trace elements. Science 213:1332-38
66. Michels KB, Edward G, Joshipura KJ, Rosner BA, Stampfer MJ, et al. 2000. Prospective study of fruit and vegetable consumption and incidence of colon and rectal cancers. J. Natl. Cancer Inst. 92: 1740-52
67. Micozzi MS, Brown ED, Taylor PR, Wolfe E. 1988. Carotenodermia in men with elevated carotenoid intake from foods and beta-carotene supplements. Am. J. Clin. Nutr. 48:1061-64
68. Milner JA, Allison RG, Elliott JG, Go VL, Miller GA, et al. 2003. Opportunities and challenges for future nutrition research in cancer prevention: a panel discussion. J. Nutr. 133:2502-48
69. National Research Council. 1989. Diet and Health: Implications for Reducing Chronic Disease Risk. Washington, DC: Natl. Acad. Press
70. Newmark HL, Lipkin M. 1997. Dietary calcium and vitamin D as inhibitors of colon and breast carcinogenesis. In Food Factors for Cancer Prevention, ed. H Ohigashi, pp. 401-7. Tokyo: Springer-Verlag
71. Newmark HL, Yang K, Lipkin M, Kopelovich L, Liu Y, et al. 2001. A Western-style diet induces benign and malignant neoplasms in the colon of normal C57B1/6 mice. Carcinogenesis 22:1871-75
72. Obermueller-Jevic UC, Espiritu I, Corbacho AM, Cross CE, Witschi H. 2002. Lung tumor development in mice exposed to tobacco smoke and fed beta-carotene diets. Toxicol. Sci. 69:23-29
73. Omenn GS, Goodman GE, Thornquist MD, Balmes J, Cullen MR, et al. 1996. Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. N. Engl. J. Med. 334:1150-55
74. Papadimitrakopoulou VA, Clayman GL, Shin DM, Myers JN, Gillenwater AM, et al. 1999. Biochemoprevention for dysplastic lesions of the upper aerodigestive tract. Arch. Otolaryngol. Head Neck Surg. 125:1083-89
75. Papadimitrakopoulou VA, Hong WK, Lee JS, Martin JW, Lee JJ, et al. 1997. Low-dose isotretinoin versus beta-carotene to prevent oral carcinogenesis: long-term follow-up. J. Natl. Cancer Inst. 89:257-58
76. Peters U, Sinha R, Chatterjee N, Subar AF, Ziegler RG, et al. 2003. Dietary fibre and colorectal adenoma in a colorectal cancer early detection programme. Lancet 361:1491-95
77. Peto R. 1981. Cancer, cholesterol, carotene, and tocopherol. Lancet 2:97-98
78. Peto R, Doll R, Buckley JD, Sporn MB. 1981. Can dietary beta-carotene materially reduce human cancer rates? Nature 290:201-8
79. Pitot HC. 1989. Progression: the terminal stage in carcinogenesis. Jpn. J. Cancer Res. 80:599-607
80. Reddy BS. 1986. Dietary fat and cancer: specific action or caloric effect. J. Nutr. 116:1132-35
81. Reddy BS. 1987. Dietary fiber and colon cancer: animal model studies. Prev. Med. 16:559-65
82. Reddy BS. 1999. Prevention of colon carcinogenesis by components of dietary fiber. Anticancer Res. 19:3681-83
83. Schatzkin A, Lanza E, Corle D, Lance P, Iber F, et al. 2000. Lack of effect of a low-fat, high-fiber diet on the recurrence of colorectal adenomas. Polyp Prevention Trial Study Group. N. Engl. J. Med. 342:1149-55
84. Shin DM, Mao L, Papadimitrakopoulou VM, Clayman G, El-Naggar A, et al. 2000. Biochemopreventive therapy for patients with premalignant lesions of the head and neck and p53 gene expression. J. Natl. Cancer Inst. 92:69-73
85. Slaga TJ. 1984. Mechanisms involved in two-stage carcinogenesis in mouse skin. In Mechanisms of Tumor Promotion, ed. TJ Slaga, pp. 1-93. Boca Raton: CRC Press
86. Slaga TJ, Fischer SM, Weeks CE, Klein-Svanto AJP. 1980. Multistage carcinogenesis. In Biochemistry of Normal and Abnormal Epidermal Differentiation, ed. M Seije, IA Bernstein, pp. 19-38. Tokyo: Univ. Tokyo Press
87. Slattery ML, Curtin K, Anderson K, Ma KN, Ballard L, et al. 2000. Associations between cigarette smoking, lifestyle factors, and microsatellite instability in colon tumors. J. Natl. Cancer Inst. 92:1831-36
88. Sorenson AW, Slattery ML, Ford MH. 1988. Calcium and colon cancer: a review. Nutr. Cancer 11:135-15
89. Spitz MR, Fueger JJ, Beddingfield NA, Annegers JF, Hsu TC, et al. 1989. Chromosome sensitivity to bleomycin-induced mutagenesis, an independent risk factor for upper aerodigestive tract cancers. Cancer Res. 49:4626-28
90. Spitz MR, Hoque A, Trizna Z, Schantz SP, Amos CI, et al. 1994. Mutagen sensitivity as a risk factor for second malignant tumors following malignancies of the upper aerodigestive tract. J. Natl. Cancer Inst. 86:1681-84
91. Sporn MB. 1976. Approaches to prevention of epithelial cancer during the preneoplastic period. Cancer Res. 36:2699-702
92. Sporn MB, Dunlop NM, Newton DL, Smith JM. 1976. Prevention of chemical carcinogenesis by vitamin A and its synthetic analogs (retinoids). Fed. Proc. 35:1332-38
93. Stanley LA. 1995. Molecular aspects of chemical carcinogenesis: the roles of oncogenes and tumour suppressor genes. Toxicology 96:173-94
94. Stich HF, Tsang SS. 1989. Promoting activity of betel quid ingredients and their inhibition by retinol. Cancer Lett. 45:71-77
95. Sun SY, Yue P, Kelloff GJ, Steele VE, Lippman SM, et al. 2001. Identification of retinamides that are more potent than N-(4-hydroxyphenyl) retinamide in inhibiting growth and inducing apoptosis of human head and neck and lung cancer cells. Cancer Epidemiol. Biomarkers Prev. 10:595-601
96. Sun SY, Yue P, Wu GS, El-Deiry WS, Shroot B, et al. 1999. Implication of p53 in growth arrest and apoptosis induced by the synthetic retinoid CD437 in human lung cancer cells. Cancer Res. 59:2829-33
97. Teris M. 1964. Goldberger on Pellagra. Baton Rouge: Louisiana State Univ. Press
98. Tsiklakis K, Papadakou A, Angelopoulos AP. 1987. The therapeutic effect of an aromatic retinoid (RO-109359) on hamster buccal pouch carcinomas. Oral Surg. Oral Med. Oral Pathol. 64:327-32
99. Umar A, Viner JL, Anderson WF, Hawk ET. 2003. Development of COX inhibitors in cancer prevention and therapy. Am. J. Clin. Oncol. 26:848-57
100. US Department of Health and Human Services. 1988. The Surgeon General's Report on Nutrition and Health. DHHS Publ. No. (PHS) 88-50210. Washington, DC: GPO
101. Wang XD, Liu C, Bronson RT, Smith DE, Krinsky NI, Russell M. 1999. Retinoid signaling and activator protein-1 expression in ferrets given beta-carotene supplements and exposed to tobacco smoke. J. Natl. Cancer Inst. 91:60-66
102. Wang XD, Russell RM. 1999. Procarcinogenic and anticarcinogenic effects of beta-carotene. Nutr. Rev. 57:263-72
103. Waterland RA, Jirtle RL. 2003. Transposable elements: targets for early nutritional effects on epigenetic gene regulation. Mol. Cell Biol. 23:5293-300
104. Weinstein IB, Carothers AM, Santella RM, Perera FP. 1995. Molecular mechanisms of mutagenesis and multistage carcinogenensis. In The Molecular Basis of Cancer, ed. J Mendelsohn, PM Howley, MA Israel, LA Liott, pp. 59-85. Philadelphia, PA: Saunders
105. Weir HK, Thun MJ, Hankey BF, Ries LAG, Howe HL, et al. 2003. Annual report to the nation on the status of cancer, 1975-2000, featuring the uses of surveillance data for cancer prevention and control. J. Natl. Cancer Inst. 95:1276-99
106. Willet WC. 1999. Nutritional Epidemiology. New York: Oxford Univ. Press
107. Women's Health Initiative Study Group. 1998. Design of the Women's Health Initiative Clinical Trial and Observational Study. Control Clin. Trials 19(1):61-109
108. Wu X, Gu J, Hong WK, Lee JJ, Amos CI, et al. 1998. Benzo[a]pyrene diol epoxide and bleomycin sensitivity and susceptibility to cancer of upper aerodigestive tract. J. Natl. Cancer Inst. 90:1393-99